GP and paediatrics specialist Dr David Capehorn provides an update for GPs on recognition and management of infectious ...

Visakhapatnam/Kakinda: Scrub typhus is spreading rapidly in Visakhapatnam district, with over 130 cases reported so far. According to doctors, the dis.

Tovorafenib provides durable disease control in pediatric patients with relapsed or refractory low-grade glioma harboring ...

Gomekli showed an 87% overall response rate in pediatric low-grade glioma with MAPK pathway activation, with a recommended ...

Updated data expands clinically meaningful results available from FIREFLY-1 pivotal trial 77% of patients who entered the ...

The FDA approved the combination of pembrolizumab (Keytruda) and enfortumab vedotin-ejfv (Padcev) for neoadjuvant and ...

Immune checkpoint inhibitors have shown efficacy in other HPV-related cancers, so a phase 2 trial tested the anti-PDL-1 antibody avelumab in patients with locally advanced or metastatic penile cancer ...

Avelumab demonstrated a 17% objective response rate in advanced penile cancer, with durable responses but limited survival benefits. Avelumab shows modest, durable responses in advanced penile cancer, ...

Day One Biopharmaceuticals (DAWN) announced three-year results from the OJEMDA pivotal Phase 2 FIREFLY-1 trial in an oral presentation at the 30th ...

Measles is popping up in pockets across the country, and with holiday travel and colder weather setting in, it’s time to be ...

In the European Union (EU) Member States, QDENGA is indicated for the prevention of dengue disease in individuals from four years of age and should be administered subcutaneously as a 0.5 mL dose at a ...